Coronavirus Notebook: Drugs Old & New, Equitable Access To Vaccines, And Vial Supplies
Executive Summary
In this edition of the Coronavirus Notebook, an EU consortium uses a supercomputing platform to identify the generic drug raloxifene as a potential COVID-19 treatment, and the World Health Organization proposes a set of principles for distributing a coronavirus vaccine at global level.
You may also be interested in...
Coronavirus Notebook: Dexamethasone Reduces Deaths In Hospitalized COVID-19 Patients
The standout development in this latest Coronavirus Notebook is that the cheap and plentiful steroid dexamethasone has been shown to reduce deaths by a third in ventilated COVID-19 patients in the UK Recovery trial. In other news, there is fresh funding for smaller firms working on potential treatments and vaccines, and a number of organizations have decided to make their research tools and resources available free of charge in return for open publication of any coronavirus-related findings.
Swiss Finally Beat EMA On New Drug Approval Times
More rolling reviews, a reduction in review rounds, and a rise in applications through two international regulatory collaboration initiatives were among the factors behind a reduction in new drug authorization times in Switzerland last year. However, “submission gaps” versus other regulators remain a problem.
UK Beefs Up Health Security Body With New Vaccine Supply Role
The UK government says that the UKHSA will be able to “harness the strengths” of the Vaccines Taskforce, including its “excellent relationships with industry” and “expertise in innovation.”